JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Bond ETF
BNDX
|
+$2.3B |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$1.64B |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.55B |
| 4 |
iShares MBS ETF
MBB
|
+$1.29B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$693M |
| 2 |
CVS Health
CVS
|
+$676M |
| 3 |
Johnson & Johnson
JNJ
|
+$669M |
| 4 |
Mondelez International
MDLZ
|
+$593M |
| 5 |
UnitedHealth
UNH
|
+$572M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.25% |
| 2 | Technology | 12.49% |
| 3 | Financials | 12.17% |
| 4 | Healthcare | 9.9% |
| 5 | Consumer Discretionary | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
851
Agilent Technologies
A
$47.3B
| $62.9M | 0.01% |
782,211
-94,696
| -11% | -$7.19M |
2013 Q2
23 quarters
|
|
|
LSXMA
852
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $62.8M | 0.01% |
2,277,495
-898,317
| -28% | -$25.6M |
2016 Q2
11 quarters
|
|
853
CALL
Bristol-Myers Squibb
BMY
$125B
| $62.8M | 0.01% |
1,315,300
+193,700
| +17% | +$9.65M |
2015 Q3
14 quarters
|
|
854
First Bancorp
FBP
$4.13B
| $62.7M | 0.01% |
5,471,364
-203,449
| -4% | -$2.15M |
2013 Q2
23 quarters
|
|
855
Vanguard Morningstar Small-Cap ETF
VB
$78B
| $62.5M | 0.01% |
409,147
-117,992
| -22% | -$17.5M |
2013 Q2
23 quarters
|
|
856
iShares MSCI KLD 400 Social ETF
DSI
$5.55B
| $62.5M | 0.01% |
1,184,312
+79,646
| +7% | +$4.04M |
2013 Q2
23 quarters
|
|
|
DNKN
857
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $62.4M | 0.01% |
830,406
-209,057
| -20% | -$14.6M |
2013 Q2
23 quarters
|
|
858
Credit Acceptance
CACC
$5.48B
| $62.1M | 0.01% |
137,515
-33,916
| -20% | -$14.6M |
2013 Q2
23 quarters
|
|
|
CDK
859
DELISTED
CDK Global, Inc.
CDK
| $62M | 0.01% |
1,054,155
+831,335
| +373% | +$45.3M |
2014 Q4
17 quarters
|
|
860
CALL
Procter & Gamble
PG
$337B
| $62M | 0.01% |
595,600
+200,100
| +51% | +$19.5M |
2014 Q3
18 quarters
|
|
861
Sun Life Financial
SLF
$43.7B
| $61.5M | 0.01% |
1,601,466
+419,234
| +35% | +$15.4M |
2013 Q2
23 quarters
|
|
|
RVNC
862
DELISTED
Revance Therapeutics, Inc.
RVNC
| $61.4M | 0.01% |
3,897,870
+92,811
| +2% | +$1.61M |
2014 Q1
20 quarters
|
|
863
Popular Inc
BPOP
$10.1B
| $61.2M | 0.01% |
1,174,483
+186,357
| +19% | +$9.9M |
2013 Q2
23 quarters
|
|
864
Alnylam Pharmaceuticals
ALNY
$29.4B
| $60.9M | 0.01% |
651,939
+206,129
| +46% | +$17.2M |
2013 Q2
23 quarters
|
|
|
AUD
865
DELISTED
Audacy, Inc.
AUD
| $60.8M | 0.01% |
11,574,387
+1,662,205
| +17% | +$11M |
2013 Q2
23 quarters
|
|
|
BERY
866
DELISTED
Berry Global Group, Inc.
BERY
| $60.6M | 0.01% |
1,225,949
+1,069,791
| +685% | +$50.7M |
2015 Q4
13 quarters
|
|
867
PUT
Southwest Airlines
LUV
$20.8B
| $60.5M | 0.01% |
1,165,800
+1,034,800
| +790% | +$54.6M |
2018 Q4
1 quarter
|
|
868
HealthEquity
HQY
$7.45B
| $60.3M | 0.01% |
814,569
-55,785
| -6% | -$3.92M |
2014 Q3
18 quarters
|
|
869
Pultegroup
PHM
$22B
| $60.1M | 0.01% |
2,150,197
+578,769
| +37% | +$15.8M |
2013 Q2
23 quarters
|
|
|
QTNA
870
DELISTED
Quantenna Communications, Inc. Common Stock
QTNA
| $59.6M | 0.01% |
2,449,032
+359,383
| +17% | +$6.26M |
2016 Q4
9 quarters
|
|
871
Lockheed Martin
LMT
$117B
| $59.5M | 0.01% |
198,099
-115,898
| -37% | -$34M |
2013 Q2
23 quarters
|
|
872
CALL
Rio Tinto
RIO
$153B
| $59.4M | 0.01% |
1,010,100
+700,100
| +226% | +$38.5M |
2018 Q1
4 quarters
|
|
|
DATA
873
DELISTED
Tableau Software, Inc.
DATA
| $59.3M | 0.01% |
466,120
-526,665
| -53% | -$66.5M |
2013 Q2
23 quarters
|
|
874
Televisa
TV
$1.21B
| $59M | 0.01% |
5,331,603
+2,414,384
| +83% | +$28.7M |
2013 Q2
23 quarters
|
|
875
Agnico Eagle Mines
AEM
$93B
| $58.9M | 0.01% |
1,353,086
+11,920
| +0.9% | +$504K |
2013 Q2
23 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2019 Portfolio in Review
As of Q1 2019, JP Morgan Chase held 6,314 positions worth $490B, up 13% from $432B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q1 2019 filing shows 537 new, 2,080 increased, 2,670 reduced and 537 closed positions. Its largest new stake was Lyft: 2,510,596 shares worth $197M. The largest sale was Apple, an estimated $693M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q1 2019 buy was Lyft: 2,510,596 shares worth $197M.
- JP Morgan Chase added most to Vanguard Total International Bond ETF in Q1 2019, an estimated $2.3B increase.
- JP Morgan Chase's biggest Q1 2019 reduction was Apple, cutting an estimated $693M.
- JP Morgan Chase fully exited Twenty-First Century Fox, Inc. Class A in Q1 2019, selling an estimated $164M.
- JP Morgan Chase's ten largest holdings make up 16% of its $490B portfolio in Q1 2019.
- JP Morgan Chase opened 537 new positions and closed 537 in Q1 2019.
- JP Morgan Chase's portfolio value rose 13% quarter-over-quarter to $490B.
Based on JP Morgan Chase's 13F filing for Q1 2019, filed 7 May 2019.